New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
10:03 EDTAEIS, TPLM, TSLX, ZQK, PHH, OXLC, OIS, MWV, KOS, HEINY, DANOY, CLVS, CNC, CSH, BRCM, AGN, GRAOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Advanced Energy (AEIS) downgraded to Hold from Buy at Needham... Allergan (AGN) downgraded to Neutral from Outperform at Credit Suisse... Broadcom (BRCM) downgraded at Stifel... Cash America (CSH) downgraded to Neutral at Janney Capital... Centene (CNC) downgraded to Sell from Neutral at Citigroup... Clovis (CLVS) downgraded to Neutral from Buy at Citigroup... Danone (DANOY) downgraded to Sell from Neutral at Goldman... Heineken (HEINY) downgraded to Sell from Neutral at Goldman... Kosmos (KOS) downgraded to Neutral from Accumulate at Global Hunter... MeadWestvaco (MWV) downgraded to Neutral from Buy at Buckingham... Oil States (OIS) downgraded to Neutral from Positive at Susquehanna... Oxford Lane (OXLC) downgraded to Neutral from Buy at Ladenburg... PHH Corp. (PHH) downgraded to Neutral from Buy at Compass Point... Quiksilver (ZQK) downgraded at Monness Crespi... TPG Specialty Lending (TSLX) downgraded to Market Perform at Wells Fargo... Triangle Petroleum (TPLM) downgraded to Neutral from Buy at Global Hunter... W.R. Grace (GRA) downgraded to Buy from Conviction Buy at Goldman.
News For AEIS;AGN;BRCM;CSH;CNC;CLVS;DANOY;HEINY;KOS;MWV;OIS;OXLC;PHH;ZQK;TSLX;TPLM;GRA From The Last 14 Days
Check below for free stories on AEIS;AGN;BRCM;CSH;CNC;CLVS;DANOY;HEINY;KOS;MWV;OIS;OXLC;PHH;ZQK;TSLX;TPLM;GRA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 12, 2014
14:03 EDTBRCMKeysight enters into manufacturing test license agreement with Broadcom
Subscribe for More Information
08:02 EDTAGNPershing submits special meeting requests totaling 35% of Allergan shares
Subscribe for More Information
05:34 EDTBRCMRovi announces collaboration with Broadcom
Subscribe for More Information
05:09 EDTAGNAllergan comments on Pershing Square delivery of additional requests
Allergan (AGN) commented on Pershing Square Capital Management delivery of additional requests from stockholders owning 1.5% of Allerganís shares to call a Special Meeting of Stockholders. Allergan will review these requests in addition to the requests from stockholders owning 2.8% of Allerganís shares that were delivered on September 3. The company issued the following statement: Notwithstanding Pershing Square and Valeant Pharmaceuticals (VRX) efforts to change the subject, Allergan recognizes that what actually matters is value, and thatís what the company is focusing on delivering to stockholders. In that regard, Allerganís current strategic plan is expected to deliver a compounded annual growth rate of greater than 20% EPS growth, including estimated 2016 EPS at approximately $10.00. Allergan has already scheduled the Special Meeting for December 18. As such, the delivery of additional requests for the Special Meeting by Pershing Square is not a meaningful development. The lawsuit in California is seeking an order barring Valeant, Pershing Square, Ackman, and entities affiliated with them from voting shares that Allergan believes were acquired in violation of the federal securities laws, including insider trading. If Allerganís motion for a preliminary injunction is granted, it would prevent Valeant, Pershing Square, and Ackman from voting their shares at any meeting of stockholders.
September 11, 2014
17:27 EDTBRCMBroadcom powers new TiVo Ultra HD set-top box solution
Subscribe for More Information
11:08 EDTAGNAllergan shareholders owning 35% to ask for meeting, Reuters says
Subscribe for More Information
10:19 EDTCNCCentene management to meet with Oppenheimer
Meeting to be held in St. Louis on September 11 hosted by Oppenheimer.
09:55 EDTZQKCrocs retreats after Buckingham downgrades citing negative trends
Subscribe for More Information
09:52 EDTAGNValeant to submit consent from 35% of Allergan holders, CNBC reports
Subscribe for More Information
07:24 EDTMWVUBS to hold a conference
Global Paper & Forest Products Conference to be held in New York on September 11 with webcasted company presentations to begin at 8:30 am; not all company presentations may be webcasted. Webcast Link
September 10, 2014
17:14 EDTOXLCLeroy Scott Frantz reports 13.5% passive stake in Oxford Lane
16:03 EDTCLVSClovis announces first patient enrolled in lucitanib Phase 2 study
Subscribe for More Information
10:00 EDTTPLMOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: African Barrick Gold (ABGLY) upgraded to Neutral from Sell at Goldman... ArcelorMittal (MT) upgraded to Overweight from Underweight at Barclays... CRH Plc. (CRH) upgraded to Outperform from Underperform at Raymond James... Callon Petroleum (CPE) upgraded to Buy from Neutral at SunTrust... Coach (COH) upgraded to Overweight from Neutral at Atlantic Equities... Hartford Financial (HIG) upgraded to Outperform from Market Perform at FBR Capital... Huntsman (HUN) upgraded to Buy from Neutral at Citigroup... Imperva (IMPV) upgraded to Outperform from Perform at Oppenheimer... L Brands (LB) upgraded at Credit Suisse... Marcus (MCS) upgraded to Buy from Neutral at B. Riley... Noodles & Company (NDLS) upgraded to Buy from Neutral at UBS... Sunoco Logistics (SXL) upgraded to Overweight from Equal Weight at Barclays... Triangle Petroleum (TPLM) upgraded to Buy from Accumulate at KLR Group... Twitter (TWTR) upgraded to Buy from Neutral at UBS.
08:12 EDTBRCMApple iPhone 802.11ac support a positve for Broadcom, says Macquarie
Subscribe for More Information
07:28 EDTTPLMTriangle Petroleum upgraded to Buy from Accumulate at KLR Group
Subscribe for More Information
September 9, 2014
16:04 EDTAGNPershing Square reports 9.7% stake in Allergan, sends letter to board
Pershing Square Capital Management sent a letter to the board of Allergan that highlights several reasons why Allergan is extremely shareholder unfriendly and why now is the time for Allergan's management team to wake up. In the letter, Pershing Square said: "Since the bid was announced in April, 75% of Allerganís shareholders have sold all or a portion of their investment including the companyís largest shareholder, which has sold its entire position. These shareholders are sending the board a message. They would not have sold if they believed that Allergan stock was worth more than current values... We note CFO Jeff Edwards recent decision to retire from the company at age 53 for family reasons, and his replacement by an investor relations executive rather than an experienced public company CFO. The notion that Allergan should execute the largest acquisition in its history led by an investor relations executive is a frightening proposition. While we respect an executiveís need to retire from a company for family reasons, Edwards exit also calls into question the companyís forward earnings guidance which shareholders expected him to execute on when the Company presented these projections on July 21st. I had expected that at some point one or more directors would have woken up and smelled the coffee. There is still time for a subset of directors to rescue their reputations by taking over leadership of this process from David Pyott and his handpicked advisors and doing what you are paid $400,000 per year to do on behalf of the companyís owners."
10:27 EDTHEINYMolson slips after BTIG views speculated M&A as unlikely
Subscribe for More Information
06:57 EDTGRAW.R. Grace sees 2014-2018 sales growth 1.5X GDP
Sees 2014-2018 sales growth 1.5X GDP, 2X GDP in growth products. Sees gross margin 38%-40%. Sees adjusted EBIT growth 8%-10% per year, adjusted free cash flow >$400M per year. Sees expected share repurchase 1%-5% per year from 2014-2018. Sees adjusted EBIT ROIC >30%. Comments from slides that will be presented at the KeyBanc Basic Materials & Packaging Conference.
06:50 EDTHEINYHeineken discussing Czech operations sale with Molson, Reuters says
Subscribe for More Information
06:42 EDTAGNLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use